A case of levocetirizine-induced liver injury

Clin Mol Hepatol. 2016 Dec;22(4):495-498. doi: 10.3350/cmh.2016.0023. Epub 2016 Dec 25.

Abstract

Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease. There was only one case report of levocetirizine-induced liver toxicity, but a liver biopsy was not performed. In this article, we present the first case of levocetirizine-induced liver injury with histologic findings. A 48-year-old man was hospitalized with jaundice and generalized pruritus that had developed after 2 months of therapy with levocetirizine for prurigo nodularis. Laboratory findings revealed acute hepatitis with cholestasis. A liver biopsy demonstrated portal inflammation and hepatitis with apoptotic hepatocytes. The patient fully recovered 3 weeks after withdrawing levocetirizine. Although levocetirizine is safe and effective, physicians should be aware of its potential hepatotoxicity.

Keywords: Cholestasis; Hepatotoxicity; Levocetirizine.

Publication types

  • Case Reports

MeSH terms

  • Cetirizine / adverse effects*
  • Cetirizine / therapeutic use
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Chemical and Drug Induced Liver Injury / pathology
  • Histamine H1 Antagonists, Non-Sedating / adverse effects*
  • Histamine H1 Antagonists, Non-Sedating / therapeutic use
  • Humans
  • Hypersensitivity / drug therapy
  • Jaundice / etiology
  • Liver / pathology
  • Male
  • Middle Aged
  • Pruritus / etiology

Substances

  • Histamine H1 Antagonists, Non-Sedating
  • levocetirizine
  • Cetirizine